Studies
-
Status: Archived
Post-kala-azar Dermal Leishmaniasis (PKDL): a prospective observational study of the effectiveness and safety of an ambulatory short course treatment with AmBisome 15 mg/kg total dose
Archived by: Holly Baker | 8th August 2022